Norepinephrine

vasoactive intestinal peptide ; Homo sapiens







17 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 24108336 [General aspects of pulmonary innervation]. 2013 Sep-Oct 2
2 22660994 A 45-year-old female with hypokalemic rhabdomyolysis due to VIP-producing composite pheochromocytoma. 2012 Jun 1
3 11121793 Vasoactive intestinal peptide: cardiovascular effects. 2001 Jan 1
4 7538196 Vasoactive intestinal peptide elevates pinealocyte intracellular calcium concentrations by enhancing influx: evidence for involvement of a cyclic GMP-dependent mechanism. 1995 May 1
5 7990977 Effects of neuropeptide Y and vasoactive intestinal peptide on human venous smooth muscle in vivo. 1994 Aug 2
6 2200184 VIP neurons in the cerebral cortex. 1990 Jun 1
7 2546435 Regulation of ion transport in porcine gallbladder: effects of VIP and norepinephrine. 1989 Jul 1
8 2576679 [Vasoactive intestinal polypeptide: a potential neurotransmitter]. 1989 Sep-Oct 1
9 3250182 Effects of VIP and PHM in human intracervical arteries. 1988 1
10 2891636 Cyclic fluctuations of vasoactive intestinal polypeptide measured radioimmunologically in various regions of the human fallopian tube. 1987 Nov-Dec 1
11 2867688 Neurotransmitter modulation of VIP release from cat cerebral cortex. 1986 Jan 1
12 2875443 Intercellular communication mediated by VIP in the cerebral cortex. 1986 1
13 3534807 Fetal adrenal VIP: distribution and effect on medullary catecholamine secretion. 1986 May-Jun 1
14 3711722 Human and canine ventricular vasoactive intestinal polypeptide: decrease with heart failure. 1986 Jul 1
15 2415954 Neuropeptidergic control of cyclic AMP accumulation in human thyroid cell. 1985 Jul-Aug 1
16 2984004 alpha 2-Adrenoceptors in the HT 29 human colon adenocarcinoma cell line: characterization with [3H]clonidine; effects on cyclic AMP accumulation. 1985 Jan 2 2
17 6400363 Neuropeptides in cardiovascular control. 1984 Dec 1